Literature DB >> 9392580

Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion).

I Järvelä1, T Autti, S Lamminranta, L Aberg, R Raininko, P Santavuori.   

Abstract

A total of 36 patients with Batten disease (juvenile-onset neuronal ceroid lipofuscinosis), homozygous or heterozygous for the major mutation, a 1.02-kb deletion, in the CLN3 gene, were studied to relate their genotype to their clinical phenotype. The onset of visual failure and epilepsy was highly concordant in both groups. Great inter- and intrafamilial heterogeneity was demonstrated in the development of mental and physical handicap and in magnetic resonance imaging findings among both homozygous and heterozygous patients. The 1.02-kb deletion in homozygous form was always associated with mental and physical handicap, whereas the heterozygous phenotype could be extremely benign without affecting the intellectual level of the patient. Our data suggest that genetic background, modifying genes, and environmental factors all influence the final phenotype of Batten disease.

Entities:  

Mesh:

Year:  1997        PMID: 9392580     DOI: 10.1002/ana.410420517

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

2.  Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  Heather R Adams; Christopher A Beck; Erika Levy; Rachel Jordan; Jennifer M Kwon; Frederick J Marshall; Amy Vierhile; Erika F Augustine; Elisabeth A de Blieck; David A Pearce; Jonathan W Mink
Journal:  Dev Med Child Neurol       Date:  2010-02-19       Impact factor: 5.449

Review 3.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

4.  Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).

Authors:  Fred K Chen; Xiao Zhang; Jonathan Eintracht; Dan Zhang; Sukanya Arunachalam; Jennifer A Thompson; Enid Chelva; Dominic Mallon; Shang-Chih Chen; Terri McLaren; Tina Lamey; John De Roach; Samuel McLenachan
Journal:  Doc Ophthalmol       Date:  2018-11-16       Impact factor: 2.379

5.  JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence.

Authors:  Taina H Autti; Janne Hämäläinen; Minna Mannerkoski; Koen Van Van Leemput; Laura E Aberg
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

Review 6.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

Review 7.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

8.  Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.

Authors:  Xiao Zhang; Dan Zhang; Jennifer A Thompson; Shang-Chih Chen; Zhiqin Huang; Luke Jennings; Terri L McLaren; Tina M Lamey; John N De Roach; Fred K Chen; Samuel McLenachan
Journal:  Mol Genet Genomic Med       Date:  2021-01-26       Impact factor: 2.183

9.  An Unusual Presentation of CLN3-Associated Batten Disease With Classic Histopathologic and Ultrastructural Findings.

Authors:  Lucy P Evans; Katherine N Gibson-Corley; Robert F Mullins; Budd A Tucker; Amy Trent; Edwin M Stone; Karra A Jones
Journal:  J Neuropathol Exp Neurol       Date:  2021-07-27       Impact factor: 3.685

10.  Characterizing upper limb function in the context of activities of daily living in CLN3 disease.

Authors:  Hanna Hildenbrand; Jordan Wickstrom; Rebecca Parks; Cris Zampieri; Thuy-Tien Nguyen; Audrey Thurm; Kisha Jenkins; Katharine E Alter; Jesse Matsubara; Dylan Hammond; Ariane Soldatos; Forbes D Porter; An N Dang Do
Journal:  Am J Med Genet A       Date:  2021-02-08       Impact factor: 2.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.